Abstract
The aim of this study was to describe gray-scale appearance of liver parenchyma and focal nodular hyperplasia (FNH) by pulse inversion (PI) ultrasound (US) at baseline and after contrast agent administration in patients with normal and fatty liver. Sixteen consecutive patients (12 women, 4 men) with 29 previously diagnosed FNHs (15 of 29 located in normal liver and 14 of 29 in fatty liver) underwent PI US before and after SH U 508A (Levovist) injection. Signal intensity values were measured within the FNHs and the adjacent liver parenchyma in selected images. Baseline echogenicity of fatty liver was higher (15.19±2.90 dB±SD) than normal liver (10.91±3.15 dB±SD; p<0.001). After Levovist administration, normal livers (7 of 16) showed a statistically significant increase of echogenicity (16.59±3.81 dB±SD; p<0.001) in comparison with fatty livers (9 of 16; 15.75±3.12 dB±SD). The FNHs located in normal liver showed baseline echogenicity higher (12.29±3.22 dB±SD) than that of FNHs arising in fatty liver (7.06±2.43 dB±SD; p<0.001). After Levovist administration, FNHs located in normal liver showed a statistically significant increase of echogenicity (25.30±4.62 dB±SD) in comparison with FNHs located in fatty liver (13.58±3.54 dB±SD; p<0.001); the latter always showed mean values of echogenicity lower than surrounding liver parenchyma. In our series decreased contrast-enhancement pattern of both fatty liver and FNHs located in fatty liver was the most prominent finding when Levovist is administered. Contrast washout was a distinctive feature of FNH arising from the fatty liver.
Similar content being viewed by others
References
Ros PR, Menu Y, Vilgrain V et al. (2001) Liver neoplasms and tumor-like conditions. Eur Radiol 11 (Suppl 2):S145–S165
Cherqui D, Rahmouni A, Charlotte F et al. (1995) Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology 22:1674–1681
Vilgrain V, Flejou JF, Arrivé L et al. (1992) Focal nodular hyperplasia of the liver: MR imaging and pathologic correlation in 37 patients. Radiology 184:699–703
Pain JA, Gimson AES, Williams R, Howard ER (1991) Focal nodular hyperplasia of the liver: results of treatment and options in management. Gut 32:524–527
Belghiti J, Pateron D, Panis Y et al. (1993) Resection of presumed benign liver tumours. Br J Surg 80:380–383
Harvey CJ, Albrecht T (2001) Ultrasound of focal liver lesions. Eur Radiol 11:1578–1593
Wang LY, Wang JH, Lin ZY et al. (1997) Hepatic focal nodular hyperplasia: findings on color Doppler ultrasound. Abdom Imaging 22:178–181
Uggowitzer M, Kugler C, Gröll R et al. (1998) Sonographic evaluation of focal nodular hyperplasias (FNH) of the liver with a transpulmonary galactose-based contrast agent (Levovist). Br J Radiol 71:1026–1032
Hosten N, Puls R, Bechstein WO, Felix R (1999) Focal liver lesions: Doppler ultrasound. Eur Radiol 9:428–435
Uggowitzer MM, Kugler C, Mischinger HJ et al. (1999) Echo-enhanced Doppler sonography of focal nodular hyperplasia of the liver. J Ultrasound Med 18:445–451
Burns PN, Wilson SR, Simpson DH (2000) Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol 35:58–71
Burns PN, Hope Simpson D, Averkiou M (2000) Nonlinear imaging. Ultrasound Med Biol 26:19–22
Dill-Macky MJ, Burns PN, Khalili K, Wilson SR (2002) Focal hepatic masses: enhancement patterns with SH U 508 A and pulse-inversion US. Radiology 222:95–102
Bertolotto M, Dalla Palma L, Quaia E, Locatelli M (2000) Characterization of unifocal liver lesions with pulse-inversion harmonic imaging after Levovist injection: preliminary results. Eur Radiol 10:1369–1376
Wilson SR, Burns PN (2001) Liver mass evaluation of ultrasound: the impact of of microbubble contrast agents and pulse-inversion imaging. Semin Liver Dis 21:147–159
Konno K, Ishida H, Sato M et al. (2001) Liver tumors in fatty liver: difficulty in ultrasonographic interpretation. Abdom Imaging 26:487–491
Dalla Palma L, Bertolotto M (1999) Introduction to ultrasound contrast agents: physics overview. Eur Radiol 9 (Suppl 3):S338–S342
Foley D, Jochem RJ (1991) Computed tomography: focal and diffuse liver disease. Radiol Clin North Am 29:1213–1222
Blomley MKJ, Albrecth T, Cosgrove DO et al. (1999) Improved imaging of the liver metastases with stimulated acustic emission in the late phase of enhancement with the US contrast agent SH U 508A: early experience. Radiology 210:409–416
Herbay A von, Vogt C, Haussinger D (2002) Late-phase pulse-inversion sonography using the contrast agent Levovist: differentiation between benign and malignant focal lesions of the liver. Am J Roentgenol 179:1273–1279
Bartolozzi C, Lencioni R, Paolicchi A et al. (1997) Differentiation of hepatocellular adenoma and focal nodular hyperplasia of the liver: comparison of power Doppler imaging and conventional color Doppler sonography. Eur Radiol 7:1410–1415
Strobel D, Krodel U, Martus P et al. (2000) Clinical evaluation of contrast-enhanced color Doppler sonography in the differential diagnosis of liver tumors. J Clin Ultrasound 28:1–13
Leen E (2001) The role of contrast-enhanced ultrasound in the characterisation of focal liver lesions. Eur Radiol 11 (Suppl 3):S27–S34
Wilson SR, Burns PN, Muradali D et al. (2000) Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis. Radiology 215:153–161
Kim TK, Choi BI, Han JK et al. (2000) Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US. Radiology 216:411–417
Tanaka S, Ioka T, Oshikawa O et al. (2001) Dynamic sonography of hepatic tumors. Am J Roentgenol 177:799–805
Wilson SR, Burns PN (2001) Liver mass evaluation of ultrasound: the impact of of microbubble contrast agents and pulse-inversion imaging. Semin Liver Dis 21:147–159
Quaia E, Bertolotto M, Dalla Palma L (2002) Characterization of liver hemangiomas with pulse-inversion harmonic imaging. Eur Radiol 12:537–544
Herbay A von, Vogt C, Haussinger D (2002) Pulse-inversion sonography in the early phase of the sonographic contrast agent Levovist: differentiation between benign and malignant focal liver lesions. J Ultrasound Med 21:1191–2000
Lencioni R, Cioni D, Bartolozzi C (2002) Tissue harmonic and contrast agent and contrast-specific imaging: back to gray scale in ultrasound. Eur Radiol 12:151–165
Mattrey RF, Kono Y (1999) Parenchymal enhancement on gray-scale in normal and pathologic tissues. Eur Radiol 9 (Suppl 3):S359–S363
Buetow PC, Pantongrag-Brown L, Buck JL, Ros P, Goodman ZD (1999) Focal nodular hyperplasia of the liver: radiologic–pathologic correlation. Radiographics 16:369–388
Horton KM, Bluemke DA, Hruban RH, Soyer P, Fishman EK (1999) CT and MR imaging of benign hepatic and biliary tumors. Radiographics 19:431–451
Nino-Murcia M, Olcott EW, Jeffrey RB, Lamm RL, Beaulieu CF, Jain KA (2000) Focal liver lesions: pattern-based classification scheme for enhancement at arterial phase CT. Radiology 215:746–751
Bartolotta TV, Midiri M, Galia M, Carcione A, De Maria M, Lagalla R (2001) Benign hepatic tumors: MRI features before and after superparamagnetic iron oxide administration. Radiol Med 101:219–229
Author information
Authors and Affiliations
Corresponding author
Additional information
This paper has been accepted for presentation as a scientific paper at the Scientific Assembly and Annual Meeting of the ECR 2003.
Rights and permissions
About this article
Cite this article
Bartolotta, T.V., Midiri, M., Scialpi, M. et al. Focal nodular hyperplasia in normal and fatty liver: a qualitative and quantitative evaluation with contrast-enhanced ultrasound. Eur Radiol 14, 583–591 (2004). https://doi.org/10.1007/s00330-003-2089-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-003-2089-z